Smart Regulation: Will the government's strategy work?
-
Published:2005-12-06
Issue:12
Volume:173
Page:1469-1470
-
ISSN:0820-3946
-
Container-title:Canadian Medical Association Journal
-
language:en
-
Short-container-title:Canadian Medical Association Journal
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. From sandbox to pandemic: Agile reform of Canadian drug regulation;Health Policy;2021-09
2. Ebola vaccine innovation: a case study of pseudoscapes in global health;Critical Public Health;2019-06-04
3. Just Evidence: Opening Health Knowledge to a Parliament of Evidence;Science, Information, and Policy Interface for Effective Coastal and Ocean Management;2016-04-28
4. Pharmaceutical Knowledge Governance: A Human Rights Perspective;Journal of Law, Medicine & Ethics;2013
5. Background: drug approval, drug patenting, pharmaceutical linkage, and public health policy * *This chapter is based upon material in: M. Sawicka and R.A. Bouchard, ‘Empirical Analysis of Canadian Drug Approval Data 2001–2008: Are Canadian Pharmaceutical Players “Doing More With Less?”’ McGill Journal of Law & Health 3: 87–151 (2009); R.A. Bouchard, J. Sawani, C. McLelland, M. Sawicka, and R. Hawkins, ‘The Pas de Deux of Pharmaceutical Regulation and Innovation: Who’s Leading Whom?’ Berkeley Technology Law Journal 24(3): 1461–522 (2009); R.A. Bouchard, R.W. Hawkins, R. Clark, R. Hagtvedt, and J. Sawani, ‘Empirical Analysis of Drug Approval-Patenting Linkage for High Value Pharmaceuticals,’ Northwestern Journal of Technology & Intellectual Property 8(2): 1–86 (2010).;Patently Innovative;2012